ESR1 and breast neoplasm: Breast tumors with a high expression of ER and/or PR are referred to as luminal tumors, with luminal A tumors (ER+, PR+, HER2−, Ki-67low) usually being less proliferative than luminal B tumors (ER+, PR+, HER2− or +, Ki-67high).